Clinical trials play a pivotal role in advancing public health by providing evidence on the effectiveness of interventions, treatments, and preventive measures. Through rigorous testing and monitoring, clinical trials ensure that medical interventions are safe and beneficial for diverse populations. They offer an opportunity to understand disease patterns, explore new therapies, and improve healthcare outcomes on a global scale. By engaging participants from different demographics, clinical trials can uncover unique responses to treatments, which is crucial for personalized medicine. Moreover, these trials contribute to the development of public health policies, guiding health professionals and governments in making informed decisions about resource allocation, vaccination strategies, and disease management. Their integration into public health research strengthens the foundation of evidence-based practices that ultimately enhance population health.
Speaker lineup for this track will be announced soon.
Browse all speakers →Background: Clinical trials are fundamental to advancing public health, as they generate robust evidence on the effectiveness, risk profile, and health outcomes of interventions. Statistical…
Paucity of information regarding newly emerging diseases pose public health challenges against their containment. Generating evidence appears pivotal in such scenario. COVID-19 pandemic is one such…
Objective: Mediation analysis identifies causal pathways by testing the relationships between the NCR, the OS, and an intermediate variable that mediates the relationship between the…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Clinical Trials in Public Health Research work, reviewed by the scientific committee.
Meet public health researchers, educators, and policy leaders from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Clinical Trials in Public Health Research research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Clinical Trials in Public Health Research track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Clinical Trials in Public Health Research. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Clinical Trials in Public Health Research are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IPHC 2027 is a hybrid conference — attend the Clinical Trials in Public Health Research track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
